MX2007001626A - Agentes anti-inflamatorios. - Google Patents

Agentes anti-inflamatorios.

Info

Publication number
MX2007001626A
MX2007001626A MX2007001626A MX2007001626A MX2007001626A MX 2007001626 A MX2007001626 A MX 2007001626A MX 2007001626 A MX2007001626 A MX 2007001626A MX 2007001626 A MX2007001626 A MX 2007001626A MX 2007001626 A MX2007001626 A MX 2007001626A
Authority
MX
Mexico
Prior art keywords
group
inflammatory agents
compounds
aminocaprolactamderivatives
adamantanemethyl
Prior art date
Application number
MX2007001626A
Other languages
English (en)
Inventor
David John Grainger
David John Fox
Original Assignee
Cambridge Entpr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33017302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007001626(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cambridge Entpr Ltd filed Critical Cambridge Entpr Ltd
Publication of MX2007001626A publication Critical patent/MX2007001626A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)

Abstract

La invencion proporciona compuestos, composiciones y usos de compuestos de la formula general (I), o sales de ellos aceptables para uso farmaceutico, los cuales son derivados de 3-aminocaprolactama, para la preparacion de un medicamento dirigido a tratar un trastorno anti-inflamatorio en donde X es -CO-Y(R1)n o SO2-Y-(R1)n; y Y es un grupo 0 cicloalquilo o policicloalquilo (tal como un grupo adamantilo, adamantanometilo, biciclooctilo, ciclohexilo, ciclopropilo); o es un grupo 0 cicloalquenilo o policicloalquenilo.
MX2007001626A 2004-08-11 2005-08-10 Agentes anti-inflamatorios. MX2007001626A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0417863A GB2418425B (en) 2004-08-11 2004-08-11 Anti-inflammatory agents
PCT/GB2005/003133 WO2006016152A1 (en) 2004-08-11 2005-08-10 Anti-inflammatory agents

Publications (1)

Publication Number Publication Date
MX2007001626A true MX2007001626A (es) 2007-06-25

Family

ID=33017302

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007001626A MX2007001626A (es) 2004-08-11 2005-08-10 Agentes anti-inflamatorios.

Country Status (22)

Country Link
US (2) US7691845B2 (es)
EP (1) EP1781299B1 (es)
JP (2) JP4991540B2 (es)
KR (1) KR101341965B1 (es)
CN (1) CN101014347B (es)
AT (1) ATE492280T1 (es)
AU (1) AU2005271062B2 (es)
BR (1) BRPI0514250A (es)
CA (1) CA2576257C (es)
DE (1) DE602005025493D1 (es)
DK (1) DK1781299T3 (es)
ES (1) ES2357588T3 (es)
GB (1) GB2418425B (es)
HK (1) HK1099200A1 (es)
IL (1) IL181055A (es)
MX (1) MX2007001626A (es)
NO (1) NO20071321L (es)
NZ (1) NZ553718A (es)
PL (1) PL1781299T3 (es)
RU (2) RU2410376C2 (es)
WO (1) WO2006016152A1 (es)
ZA (1) ZA200700827B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2418425B (en) 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
GB2430674B (en) * 2005-08-10 2010-11-17 Univ Cambridge Tech Anti-inflammatory agents
JP5209471B2 (ja) 2005-06-15 2013-06-12 ケンブリッジ・エンタープライズ・リミテッド 抗炎症剤
GB2451451A (en) * 2007-07-30 2009-02-04 Inion Ltd Osteogenic compounds
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
GB2455539B (en) * 2007-12-12 2012-01-18 Cambridge Entpr Ltd Anti-inflammatory compositions and combinations
GB201009603D0 (en) * 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent
CN105367495B (zh) * 2014-08-29 2019-07-23 中国人民解放军第二军医大学 含有七元内酰胺环的荜拔酰胺类似物及其制备与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2758822A1 (de) * 1977-12-30 1979-07-05 Diehl Gmbh & Co Verfahren zur herstellung eines kupfer-zink-werkstoffs
DE3217373A1 (de) 1982-05-08 1983-11-10 Bayer Ag, 5090 Leverkusen Sulfinyl- und sulfonyl-azacycloheptan-2-one, verfahren zu ihrer herstellung sowie ihre verwendung als futterzusatzstoffe
US4908445A (en) * 1989-01-09 1990-03-13 Harbor Branch Oceanographic Institution, Inc. Sesquiterpene compounds and pharmaceutical compositions containing same, from pachastrella sponges
IT1247698B (it) * 1990-06-21 1994-12-30 Sigma Tau Ind Farmaceuti 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
GB9026256D0 (en) * 1990-12-03 1991-01-16 Fujisawa Pharmaceutical Co Hexahydroazepine derivatives
JP3633060B2 (ja) 1995-09-22 2005-03-30 Ｊｓｒ株式会社 低結晶性エチレン系ランダム共重合体およびその組成物
EP0946561B1 (en) * 1996-12-20 2002-02-13 AstraZeneca AB Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
JP3690052B2 (ja) * 1997-03-24 2005-08-31 Ｊｓｒ株式会社 オイルゲル化剤
JP2003146972A (ja) 2001-11-14 2003-05-21 Teikoku Hormone Mfg Co Ltd カルボスチリル誘導体
KR100606102B1 (ko) * 2002-08-03 2006-07-28 삼성전자주식회사 방송/통신 통합형 수동 광네트웍 시스템
AU2003263393A1 (en) * 2002-09-04 2004-03-29 Glenmark Pharmaceuticals Limited New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
US7326677B2 (en) 2003-07-11 2008-02-05 The Procter & Gamble Company Liquid laundry detergent compositions comprising a silicone blend of non-functionalized and amino-functionalized silicone polymers
EP1717225A4 (en) 2004-02-18 2009-10-21 Kyorin Seiyaku Kk BICYCLIC AMIDE DERIVATIVES
GB2418425B (en) 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
US20120040160A1 (en) * 2007-01-29 2012-02-16 Guardian Industries Corp. Method of making heat treated and ion-beam etched/milled coated article using diamond-like carbon (dlc) protective film
US20120015195A1 (en) * 2007-01-29 2012-01-19 Guardian Industries Corp. and C.R.V.C. Method of making heat treated and ion-beam etched/milled coated article using diamond-like carbon (dlc) coating and protective film
US20120015196A1 (en) * 2007-01-29 2012-01-19 Guardian Industries Corp. Method of making heat treated coated article using diamond-like carbon (dlc) coating and protective film on acid-etched surface

Also Published As

Publication number Publication date
DK1781299T3 (da) 2011-03-28
US7691845B2 (en) 2010-04-06
CA2576257C (en) 2013-02-12
GB2418425A (en) 2006-03-29
AU2005271062A1 (en) 2006-02-16
RU2007104519A (ru) 2008-09-20
EP1781299A1 (en) 2007-05-09
CN101014347A (zh) 2007-08-08
PL1781299T3 (pl) 2011-05-31
KR20070060081A (ko) 2007-06-12
JP2012140444A (ja) 2012-07-26
US8497261B2 (en) 2013-07-30
KR101341965B1 (ko) 2013-12-17
RU2410376C2 (ru) 2011-01-27
NZ553718A (en) 2010-02-26
HK1099200A1 (en) 2007-08-10
BRPI0514250A (pt) 2008-06-03
GB2418425B (en) 2008-09-03
RU2010142847A (ru) 2012-04-20
ATE492280T1 (de) 2011-01-15
ES2357588T3 (es) 2011-04-27
US20080194541A1 (en) 2008-08-14
CN101014347B (zh) 2011-04-13
US20100292213A1 (en) 2010-11-18
IL181055A (en) 2011-03-31
JP4991540B2 (ja) 2012-08-01
GB0417863D0 (en) 2004-09-15
AU2005271062B2 (en) 2011-04-14
ZA200700827B (en) 2008-09-25
WO2006016152A1 (en) 2006-02-16
CA2576257A1 (en) 2006-02-16
JP2008509210A (ja) 2008-03-27
DE602005025493D1 (de) 2011-02-03
NO20071321L (no) 2007-05-11
IL181055A0 (en) 2007-07-04
EP1781299B1 (en) 2010-12-22

Similar Documents

Publication Publication Date Title
MX2007001626A (es) Agentes anti-inflamatorios.
TW200619199A (en) 3-carbamoyl-2-pyridone derivatives
TW200726765A (en) Triazolopyridine cannabinoid receptor 1 antagonists
PT2038290E (pt) Moduladores de receptor do tipo toll 7
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BRPI0509074A (pt) composições farmacêuticas compreendendo agonistas do receptor da tiróide
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
TW200630361A (en) Integrin antagonists useful as anticancer agents
MX2010004232A (es) Compuesto de indolina de pirimidilo.
MY152176A (en) Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
MX2009010559A (es) Derivados de heteroarilo.
WO2006018609A3 (en) Anti-inflammatory agents
EP2023724B8 (de) Synergistische wirkstoffkombinationen
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
WO2006134385A3 (en) Anti-inflammatory agents
WO2007064620A3 (en) Compositions comprising a combination of ccr5 and cxcr4 antagonists
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200735864A (en) Immediate release pharmaceutical formulation
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
MY153733A (en) Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
MY160963A (en) Sustained-release therapeutic agent for hypertension and renal dysfunction
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MXPA05010957A (es) Derivados de ornitina activos farmaceuticamente, sales de amonio de los mismos y metodos para su preparacion.
WO2005035500A3 (en) Therapeutic agents useful for treating pain

Legal Events

Date Code Title Description
FG Grant or registration